Dana C. Borcherding, Ph.D.
Affiliations: | 2010 | Cell & Molecular Biology | University of Cincinnati, Cincinnati, OH |
Area:
Cell Biology, Medicine and Surgery, Molecular BiologyGoogle:
"Dana Borcherding"Parents
Sign in to add mentor| Nira Ben-Jonathan | grad student | 2010 | University of Cincinnati | |
| (Human Adipocytes: Dopamine Receptors and the Regulation of Prolactin.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ben-Jonathan N, Borcherding DC, Hugo ER. (2023) Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews in Oncogenesis. 27: 51-71 |
| Borcherding DC, Hugo ER, Fox SR, et al. (2021) Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor. Cancers. 13 |
| Ben-Jonathan N, Borcherding DC, Fox S, et al. (2019) Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1. Cancer Drug Resistance (Alhambra, Calif.). 2: 933-947 |
| Borcherding DC, Tong W, Hugo ER, et al. (2015) Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene |
| Borcherding DC, Hugo ER, Idelman G, et al. (2011) Dopamine receptors in human adipocytes: expression and functions. Plos One. 6: e25537 |
| Jacobson EM, Hugo ER, Borcherding DC, et al. (2011) Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discovery Medicine. 11: 315-24 |
| Hugo ER, Borcherding DC, Gersin KS, et al. (2008) Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. The Journal of Clinical Endocrinology and Metabolism. 93: 4006-12 |